Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.

Javaheri T, Kazemi Z, Pencik J, Pham HT, Kauer M, Noorizadeh R, Sax B, Nivarthi H, Schlederer M, Maurer B, Hofbauer M, Aryee DN, Wiedner M, Tomazou EM, Logan M, Hartmann C, Tuckermann JP, Kenner L, Mikula M, Dolznig H, Üren A, Richter GH, Grebien F, Kovar H, Moriggl R

Open source

DOI: 10.1038/cddis.2016.268
Published: 2016 Oct 13
Container: Cell death & disease
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 4/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/cddis.2016.268,
  title = {Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.},
  author = {Javaheri T and Kazemi Z and Pencik J and Pham HT and Kauer M and Noorizadeh R and Sax B and Nivarthi H and Schlederer M and Maurer B and Hofbauer M and Aryee DN and Wiedner M and Tomazou EM and Logan M and Hartmann C and Tuckermann JP and Kenner L and Mikula M and Dolznig H and Üren A and Richter GH and Grebien F and Kovar H and Moriggl R},
  year = {2016},
  journal = {Cell death \& disease},
  doi = {10.1038/cddis.2016.268},
  url = {https://doi.org/10.1038/cddis.2016.268}
}

RIS

TY  - JOUR
TI  - Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
AU  - Javaheri T
AU  - Kazemi Z
AU  - Pencik J
AU  - Pham HT
AU  - Kauer M
AU  - Noorizadeh R
AU  - Sax B
AU  - Nivarthi H
AU  - Schlederer M
AU  - Maurer B
AU  - Hofbauer M
AU  - Aryee DN
AU  - Wiedner M
AU  - Tomazou EM
AU  - Logan M
AU  - Hartmann C
AU  - Tuckermann JP
AU  - Kenner L
AU  - Mikula M
AU  - Dolznig H
AU  - Üren A
AU  - Richter GH
AU  - Grebien F
AU  - Kovar H
AU  - Moriggl R
PY  - 2016
JO  - Cell death & disease
DO  - 10.1038/cddis.2016.268
UR  - https://doi.org/10.1038/cddis.2016.268
ER  -

APA

T, J., Z, K., J, P., HT, P., M, K., R, N., B, S., H, N., M, S., B, M., M, H., DN, A., M, W., EM, T., M, L., C, H., JP, T., L, K., M, M., H, D., A, Ü., GH, R., F, G., H, K., & R, M. (2016). Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.. Cell death & disease. https://doi.org/10.1038/cddis.2016.268

Source records

pubmed · retrieved 2026-09-24T22:45:41.739Z